Clinical Trials · NCT00329797
Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Radiation Therapy Oncology Group
- Enrollment
- 109
- Start date
- Mar 2006
- Locations
- 88 sites, United States, Canada
- Primary endpoint
- Freedom From Any Bone Fracture (FABF) Rate at Three Years